Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | CBFA2T3 |
Upstream (Parents) |
---|
(<<) CD79A → CBFA2T3 |
(<<) DKFZP434I0714 → CBFA2T3 |
(<<) HLA-DOA → CBFA2T3 |
(<<) MEF2D → CBFA2T3 |
(<<) PRKCB → CBFA2T3 |
(<<) PRKCH → CBFA2T3 |
(<<) RASSF5 → CBFA2T3 |
(<<) RRAS2 → CBFA2T3 |
(<<) STAT4 → CBFA2T3 |
(<<) STAT6 → CBFA2T3 |
(<<) UBE2C → CBFA2T3 |
(<<) VAV1 → CBFA2T3 |
Downstream (Children) |
---|
CBFA2T3 → ASB2 (>>) |
CBFA2T3 → BLNK (>>) |
CBFA2T3 → CLDN5 (>>) |
CBFA2T3 → GRB10 (>>) |
CBFA2T3 → KLF2 (>>) |
CBFA2T3 → LRCH4 (>>) |
CBFA2T3 → PIP4K2A (>>) |
CBFA2T3 → PITPNC1 (>>) |
CBFA2T3 → PLOD2 (>>) |
CBFA2T3 → SOX2 (>>) |
CBFA2T3 → SP5 (>>) |
CBFA2T3 → TMCC3 (>>) |
CBFA2T3 → TRERF1 (>>) |
CBFA2T3 → UBE2I (>>) |